MOH — authorised 30 November 1979
- Marketing authorisation holder: FOUGERA PHARMS
- Status: likely_approved
MOH authorised Ocuzolin on 30 November 1979
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 November 1979.
FOUGERA PHARMS holds the Israeli marketing authorisation.